Gastro-esophageal Reflux Clinical Trial
Official title:
Evaluation of Diagnostic Performances of Esophageal Post Prandial High Resolution Impedance- Manometry (HRIM) in Patients With Gastro-esophageal Reflux Disease (GERD) Resistant to Proton Pump Inhibitor (PPI) Treatment : Pilot Study (MHR POST-PRANDIALE)
Nine to 30% of the population suffers from gastro-esophageal reflux disease (GERD) - suggestive symptoms (heartburn, regurgitation, chest pain, chronic couch, sore throat). Proton pump inhibitor (PPI) is usually the first line treatment. However 20 to 60% of patients have persistent symptoms on proton pump inhibitor. Complementary examinations are then required to determine the cause of persistent symptoms (non compliance to treatment, persistent esophageal acid exposure despite proton pump inhibitor, non acid reflux, reflux hypersensitivity, functional symptoms, rumination syndrome…). The gold standard to detect reflux episodes in patients on proton pump inhibitor therapy is 24-h ambulatory esophageal pH-impedance monitoring. Esophageal High Resolution Impedance-Manometry might help to determine gastro-esophageal reflux disease mechanisms especially when performed post prandially. Further some publications demonstrated that the number of reflux episodes detected during the post prandial period might be well correlated to the total number of reflux episodes recorded during 24 h. The hypothesis of this study is that 1-hour post prandial esophageal High Resolution Impedance-Manometry might be useful to diagnose gastro-esophageal reflux disease and can replace in some instances 24-h esophageal pH-impedance monitoring. Therefore the aim is to compare the number of reflux episodes detected with esophageal High Resolution Impedance-Manometry performed during 1-h post prandial period to the total number of reflux episodes detected during 24-h ambulatory esophageal pH-impedance monitoring.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02128867 -
Safety Study of Airway Clearance Techniques in Infants.
|
N/A | |
| Completed |
NCT00481949 -
Assessment of Gastro-esophageal Reflux Using Endo-Flip vs Bravo
|
N/A | |
| Recruiting |
NCT03669874 -
Endoscopic Fundoplication With MUSE System
|
||
| Terminated |
NCT00222079 -
Evaluation of Esomeprazole in Treating Gastro-esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy
|
N/A | |
| Not yet recruiting |
NCT05068089 -
Health, Economic Analysis and Clinical Aspects of Patients With Neurological Disabilities in Enteral Nutrition With Dedicated Formula. The Role of Nissen's Fundoplication in the Management of Gastroesophageal Reflux
|
||
| Not yet recruiting |
NCT03904004 -
Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study
|
||
| Completed |
NCT03341585 -
Influence of Expiration Lente Prolongée on Gastro-oesophageal Reflux
|
N/A | |
| Completed |
NCT01601379 -
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
|
Phase 4 | |
| Not yet recruiting |
NCT05425771 -
ARMA (Antireflux Mucosa Ablation) in Patients With Chronic Refractory Reflux Disease
|
N/A | |
| Not yet recruiting |
NCT02609620 -
Safety & Initial Efficacy of the LunGuard PFT Sys. on Enteral-Fed, Sedated and Mechanically Ventilated Patients Peristaltic Feeding Tube
|
N/A |